Scientists use nanoparticles to shut down mechanism that drives cancer growth

When scientists develop cancer therapies, they target the features that make the disease deadly: tumor growth, metastasis, recurrence and drug resistance. In epithelial cancers—cancers of the breast, ovaries, prostate, skin and bladder, which begin in the organs’ lining—these processes are controlled by a genetic program called epithelial–mesenchymal transition.